Kovitz Investment Group Partners’s CVS Health CVS Stock Holding History

Kovitz Investment Group Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,319	Closed	-$344K	–	406
2022 Q1	$344K	Sell	1,319 -764	-37%	-$80.3K	0.01%	369
2021 Q4	$1.63M	Sell	2,083 -305	-13%	-$28.2K	0.04%	226
2021 Q3	$1.42M	Buy	2,388 +1,980	+485%	+$166K	0.03%	269
2021 Q2	$1.06M	Buy	408 +10	+3%	+$819	0.02%	296
2021 Q1	$728K	Buy	398 +56	+16%	+$4.08K	0.02%	312
2020 Q4	$456K	Buy	342 +7	+2%	+$455	0.01%	339
2020 Q3	$251K	Buy	335 +11	+3%	+$684	0.01%	373
2020 Q2	$382K	Buy	324 +12	+4%	+$756	0.01%	322
2020 Q1	$324K	Buy	+312	New	+$20.8K	0.01%	323

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kovitz Investment Group Partners's CVS Position: Q1 2026 in Review

Kovitz Investment Group Partners increased its CVS Health (CVS) stake by 462% in Q1 2026, buying an estimated $17.2M and bringing the position to 270,972 shares worth $19.5M. The position accounts for 0.45% of the portfolio, ranked #57.

Kovitz Investment Group Partners first reported a position in CVS in Q1 2016 and has held it in 38 quarters since. The position peaked at $56.8M in Q4 2016. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Kovitz Investment Group Partners held 270,972 shares of CVS Health worth $19.5M as of Q1 2026.
Kovitz Investment Group Partners bought 222,781 CVS Health shares in Q1 2026, an estimated $17.2M.
CVS Health made up 0.45% of Kovitz Investment Group Partners's portfolio in Q1 2026, its #57 holding.
Kovitz Investment Group Partners first reported a position in CVS Health in Q1 2016 and has held it in 38 quarters since.
Kovitz Investment Group Partners's CVS Health position peaked at $56.8M in Q4 2016.
1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q1 2026, filed 13 May 2026.